Bio-Technology
Active

Bdellovibrio: Living Antibiotics for Aquaculture

Revolutionary predatory bacteria that hunt and eliminate Vibrio pathogens in shrimp aquaculture, offering a sustainable alternative to failed antibiotic treatments.

Started
2/1/2024
Location
Singapore
Team Size
14 researchers
Progress
45%

Project Overview

Bdellovibrio bacteriovorus represents a paradigm-shifting approach to aquaculture disease management through precision bacterial predation. This revolutionary biocontrol technology harnesses nature's own hunting mechanism to specifically target and eliminate pathogenic Vibrio species while preserving beneficial microbial communities in shrimp farming environments.

Key Objectives

  • Develop scalable Bdellovibrio cultivation systems for commercial application
  • Achieve 70% reduction in Vibrio-related mortality in shrimp farms
  • Demonstrate ecosystem preservation through selective bacterial predation
  • Create AI-controlled dosing systems for automated treatment delivery
  • Obtain regulatory approval for aquaculture biocontrol application

Progress Tracking

Overall Progress45%

Project Milestones

Predatory Mechanism Characterization
Target: 5/30/2024
Laboratory Efficacy Trials
Target: 8/15/2024
Aquaculture Pilot Program
Target: 11/1/2024
Scalable Production System
Target: 2/1/2025
Smart Integration Platform
Target: 5/1/2025
Regulatory Approval
Target: 9/1/2025

Research Impact

Addresses the $8.2 billion annual global crisis caused by vibriosis in shrimp aquaculture. This technology eliminates the need for harmful antibiotics while providing sustainable disease control that preserves marine ecosystems and ensures food security.

Project Details

Status
Active
Currently in active development
Funding
$150K of $3.2M
Duration
24 months
Tags
Biotechnology
Aquaculture
Living Antibiotics
Bacterial Predation
Marine Biology

Research Team

Dr. Marine Liu
Principal Investigator & Marine Microbiologist
Dr. Raj Patel
Aquaculture Systems Engineer
Dr. Elena Vasquez
Bacterial Predation Specialist
Dr. Chen Wei
Bioprocess Engineering Lead
Dr. Fatima Al-Zahra
Regulatory Affairs Director
Bdellovibrio: Living Antibiotics for Aquaculture | Bio-Innovation Projects